JP Morgan Chase’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
JP Morgan Chase's DNA Position: Q3 2026 in Review
JP Morgan Chase reduced its Ginkgo Bioworks (DNA) stake by 16% in Q3 2026, selling an estimated $174K and leaving 112,694 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #4567.
JP Morgan Chase first reported a position in DNA in Q3 2021 and has held it in 21 quarters since. The position peaked at $10.9M in Q1 2022. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- JP Morgan Chase held 112,694 shares of Ginkgo Bioworks worth $1.35M as of Q3 2026.
- JP Morgan Chase sold 21,346 Ginkgo Bioworks shares in Q3 2026, an estimated $174K.
- Ginkgo Bioworks made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #4567 holding.
- JP Morgan Chase first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 21 quarters since.
- JP Morgan Chase's Ginkgo Bioworks position peaked at $10.9M in Q1 2022.
- 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.